A Single-center, Randomized, Self-controlled Exploratory Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Chemotherapy in Advanced Breast Cancer
Latest Information Update: 08 Mar 2024
At a glance
- Drugs Hetrombopag (Primary) ; Thrombopoietin
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 29 Feb 2024 Planned End Date changed from 28 Jun 2024 to 28 Dec 2024.
- 29 Feb 2024 Planned primary completion date changed from 28 Oct 2023 to 28 Dec 2024.
- 29 Feb 2024 Status changed from not yet recruiting to recruiting.